Managed Health Care Connect March 25, 2021
Amy Amick, president and chief executive officer, SPH Analytics

Health Risk Assessments (HRAs) arm employers and payers with the meaty consumer health data they need to assess individual health status, prioritize engagement and to motivate behavior change. Historically, HRAs were leveraged to aggregate data, predict outcomes and costs and drive targeted engagement.

Yet no risk assessment in the world could have predicted that COVID-19 would wield such a huge impact on all patients, from the sickest to the healthiest. The coronavirus pandemic has led to more than 400,000 deaths in the United States alone, and a wide array of clinical and behavioral complications for survivors. It’s thrown a wrench into preventive care and as a result, clinical outcomes.

Within the framework of the pandemic, these risk assessments are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Healthcare System, Insurance, Patient / Consumer, Population Health Mgmt, Provider
Related Articles:
After slow start, ACA enrollment takes off
FDA updates definition of 'healthy'
CMS says record 16.6 million have signed up for Jan. 1 Marketplace coverage
How America Lost Control of the Bird Flu, Setting the Stage for Another Pandemic
How Mount Sinai doubled its hospital-at-home program

Share This Article